Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 sept. 2025 07h00 HE | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal Bone Formation

FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab is the first and only treatment to demonstrate a...
22 oct. 2013 12h44 HE | Source: abas-USA

abas-USA Announces New On-Site Training Facility

STERLING, VA--(Marketwired - Oct 22, 2013) - abas-USA is pleased to announce they will be moving and expanding their East Coast headquarters in November. The new facility will accommodate future...